Minerva Respiratory Medicine

Scope & Guideline

Transforming respiratory care with cutting-edge studies.

Introduction

Explore the comprehensive scope of Minerva Respiratory Medicine through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Minerva Respiratory Medicine in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2784-8477
PublisherEDIZIONI MINERVA MEDICA
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 2021 to 2024
AbbreviationMINERVA RESPIR MED / Minerva Respir. Med.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY

Aims and Scopes

Minerva Respiratory Medicine is dedicated to advancing the field of respiratory health through comprehensive research and clinical studies. The journal focuses on a wide range of topics within pulmonary medicine, emphasizing innovative methodologies and interdisciplinary approaches.
  1. Chronic Respiratory Diseases:
    The journal extensively covers chronic conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, examining their management, treatment outcomes, and the impact of comorbidities.
  2. Infectious Respiratory Diseases:
    A significant focus is placed on infectious diseases affecting the respiratory system, including COVID-19, tuberculosis, and pneumonia, with an emphasis on epidemiology, clinical features, and treatment strategies.
  3. Interventional Pulmonology:
    Research on interventional techniques such as bronchoscopy and endoscopic procedures is a core area, highlighting advancements in diagnostic and therapeutic approaches.
  4. Respiratory Rehabilitation and Patient Quality of Life:
    The journal explores the role of rehabilitation programs and their effectiveness on patient outcomes, particularly in chronic respiratory conditions and post-viral syndromes.
  5. Emerging Technologies in Respiratory Medicine:
    There is a consistent focus on the integration of new technologies, including machine learning, telemedicine, and non-invasive ventilation strategies, to improve diagnosis and treatment.
Recent publications in Minerva Respiratory Medicine reveal a dynamic shift towards several trending and emerging themes that reflect current challenges and advancements in respiratory health.
  1. Impact of COVID-19 on Respiratory Health:
    A prominent trend is the exploration of COVID-19's implications for patients with existing respiratory conditions, including long-term sequelae and management strategies.
  2. Advancements in Telemedicine and Remote Monitoring:
    The journal shows increasing interest in telemedicine, particularly in the context of managing chronic respiratory diseases and enhancing patient engagement during the pandemic.
  3. Personalized and Targeted Therapies:
    Research focusing on personalized medicine, including biomarker-driven therapies and patient-specific treatment plans, is emerging as a significant theme in the journal.
  4. Interdisciplinary Approaches to Respiratory Care:
    There is a growing trend towards collaborative studies that integrate various medical specialties to address complex respiratory issues, enhancing holistic patient care.
  5. Role of Artificial Intelligence in Respiratory Medicine:
    The integration of artificial intelligence and machine learning into respiratory diagnostics and treatment is becoming increasingly prominent, reflecting technological advancements in the field.

Declining or Waning

While Minerva Respiratory Medicine continues to thrive in many areas, certain themes have shown a decline in focus over recent years. These waning scopes reflect shifting priorities and emerging challenges in the field.
  1. Traditional Pharmacological Approaches:
    There appears to be a declining emphasis on conventional pharmacological treatments for respiratory diseases, as the journal increasingly highlights novel therapies and personalized medicine.
  2. Basic Research on Lung Physiology:
    Research specifically focused on fundamental aspects of lung physiology seems to be less frequently published, possibly overshadowed by clinical and translational studies.
  3. Environmental and Occupational Lung Diseases:
    There has been a noticeable reduction in articles addressing environmental and occupational factors affecting lung health, indicating a potential shift towards more acute and infectious respiratory conditions.

Similar Journals

Respiratory Care

Shaping the Landscape of Critical Care Medicine.
Publisher: DAEDALUS ENTERPRISES INCISSN: 0020-1324Frequency: 12 issues/year

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

Egyptian Journal of Bronchology

Transforming insights into action for better respiratory care.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Advances in Respiratory Medicine

Catalyzing advancements in respiratory care.
Publisher: MDPIISSN: 2451-4934Frequency: 6 issues/year

Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.

Pulmonary Medicine

Elevating Knowledge in Respiratory Research
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

LUNG

Elevating respiratory medicine through rigorous research.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Pulmonology

Pioneering insights for a healthier tomorrow in pulmonology.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

BMJ Open Respiratory Research

Empowering knowledge exchange in pulmonary medicine.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.

Therapeutic Advances in Respiratory Disease

Empowering Progress in Respiratory Disease Management
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4658Frequency: 1 issue/year

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

Thoracic Research and Practice

Exploring New Frontiers in Thoracic Research
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

THORAX

Exploring the frontiers of respiratory medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.